Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study

Cancer
Alba A BrandesM Ermani

Abstract

To the authors' knowledge, there is a scarcity of accurate data regarding the feasibility of standard chemotherapy with procarbazine, lomustine, and vincristine (PCV) in a homogeneous series of patients with primary anaplastic oligodendroglioma (AO) and oligoastrocytoma (AOA) that was recurrent after surgery and standard radiotherapy. The aim of the current study was to evaluate the overall response rate, toxicity, and time to progression (TTP) with the use of standard PCV in this setting. Between November 1994 and September 2000, 37 patients were enrolled in the current study. Of these, 23 had AO (62%) and 14 had AOA (38%). All patients received standard PCV comprised of lomustine (110 mg/m2) on Day 1, procarbazine (60 mg/m2) on Days 8-21, and vincristine (1.4 mg/m2, maximum total 2 mg) on Days 8 and 29. Cycles were repeated every 6 weeks. There were 11 complete responses (CR; 29.7%) and 11 partial responses (PR; 29.7%) reported and 8 patients had stable disease (SD; 21.6%). The response rate was higher in patients with AO compared with patients with AOA (77.2% vs. 22.7%; P = 0. 02). The median TTP, which was 12.3 months overall, was 30.3 months in patients who achieved a CR, 19.1 months in patients who achieved a PR, and 6.1 ...Continue Reading

References

Nov 11, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L LongoR C Young
Jul 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D R MacdonaldJ G Cairncross
Mar 1, 1989·Controlled Clinical Trials·R Simon
Apr 1, 1988·Annals of Neurology·J G Cairncross, D R Macdonald
Oct 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G CairncrossC Schold
Mar 1, 1993·Neurosurgery·A P KyritsisV A Levin
Sep 5, 1998·Cancer Treatment Reviews·A A Brandes, M V Fiorentino
Mar 16, 2002·Journal of Neuropathology and Experimental Neurology·Paul KleihuesWebster K Cavenee
Jun 28, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J van den BentUNKNOWN European Organization for Research and Treatment of Cancer Brain Tumor Group
Nov 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A A BrandesM Ermani

❮ Previous
Next ❯

Citations

Jun 22, 2005·Current Treatment Options in Neurology·Warren P Mason
Dec 9, 2008·The Cancer Journal·Gregory Cairncross, Robert Jenkins
Mar 25, 2008·Therapeutics and Clinical Risk Management·Jean-Pierre ArmandLauren Abrey
Sep 1, 2014·Seminars in Oncology·Kurt A Jaeckle
Sep 3, 2010·Acta neurochirurgica·Michael D JenkinsonBrian Haylock
Jun 21, 2008·Revue neurologique·A F Hottinger, R Stupp
Aug 27, 2015·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Faycal El MajdoubMohammad Maarouf
Apr 24, 2015·CNS Oncology·Walter TaalMartin J van den Bent
Feb 15, 2014·Journal of Korean Neurosurgical Society·Ho-Shin GwakSeung Hoon Lee
Mar 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kurt A JaeckleJan C Buckner
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin J van den BentKhê Hoang-Xuan
Apr 21, 2006·Expert Review of Neurotherapeutics·Sajeel Chowdhary, Marc C Chamberlain
May 6, 2015·Expert Review of Neurotherapeutics·Emilie Le RhunMarc C Chamberlain
Jul 21, 2020·Acta Oncologica·Florian SchneiderMartin W Huellner
Feb 28, 2015·Surgical Neurology International·Emilie Le RhunMarc C Chamberlain
Oct 29, 2013·Journal of Neuro-oncology·Giuseppe MinnitiRiccardo Maurizi Enrici

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Martin J van den BentEuropean Organization for Research and Treatment of Cancer Brain Tumor Group
The New England Journal of Medicine
Roger StuppNational Cancer Institute of Canada Clinical Trials Group
© 2021 Meta ULC. All rights reserved